Self-Assembly of Small Gold Nanoparticles
A R T I C L E S
tography (silica gel, hexane:ethyl acetate ) 1:1) to give 2d (1.73 g,
82%). H NMR (300 MHz, CDCl3): δ 1.08 (m, 12H), 1.76 (m, 8H),
4.70 (t, 4H), 4.84 (m, 4H), 5.62 (m, 2H), 7.35 (m, 4H), 7.45 (m, 2H),
7.87 (m, 2H), 8.05 (t, 1H), 8.31 (d, 2H). DI-MS (EI): m/z 587, calcd
exact mass 587.399.
6H), 2.84 (t, 4H), 4.71 (t, 4H), 7.36 (m, 4H), 7.47 (m, 2H), 7.87 (m,
2H), 8.06 (t, 1H), 8.32 (d, 2H). DI-MS (EI): m/z 739, calcd exact mass
739.395.
1
2,6-Bis(1′-(12-thioacetoxydodecyl)benzimidazol-2-yl)pyridine (3e).
An acetonitrile solution (100 mL) of 2e (3.57 g, 4.4 mmol) was bubbled
with Ar for 5 min. To this solution was added potassium thioacetate
(1.26 g, 11.1 mmol), and the resulting mixture was stirred under argon
at room temperature for 2 h. The solvent was removed under reduced
pressure, diethyl ether was added, and the solution was washed with
saturated aqueous NaHCO3 solution, dried over Na2SO4, and concen-
trated under reduced pressure. The product was purified by column
chromatography (silica gel, dichloromethane:ethyl acetate ) 3:1) to
2,6-Bis(1′-(12-bromododecyl)benzimidazol-2-yl)pyridine (2e). NaH
(60%) in oil (770 mg, 19.3 mmol) was added to a three-necked flask
under an argon atmosphere, and then dry hexane was added. After the
resulting solution was stirred for 5 min, the hexane was removed with
a syringe, and dry DMAc (10 mL) was then added. BIP (2.0 g, 6.4
mmol) was added, and the resulting mixture was heated to 75 °C for
1 h. This pale yellow solution was added to the preheated dry DMAc
solution (10 mL) of 1,12-dibromododecane (3.35 mL, 28.3 mmol)
through a needle at 75 °C, and the mixture was continuously heated
for 1 h. The solution was then cooled to room temperature, and diethyl
ether was added. The resulting pale yellow solution was washed with
water, dried over Na2SO4, and concentrated under reduced pressure.
The product was purified by column chromatography (silica gel, hexane,
then ethyl acetate:methanol ) 100:1) to give 2e (3.88 g, 75%). 1H NMR
(300 MHz, CDCl3): δ 1.08 (m, 12H), 1.76 (m, 8H), 4.70 (t, 4H), 4.84
(m, 4H), 5.62 (m, 2H), 7.35 (m, 4H), 7.45 (m, 2H), 7.87 (m, 2H), 8.05
(t, 1H), 8.31 (d, 2H). DI-MS (EI): m/z 805, calcd exact mass 805.312
2,6-Bis(1′-(3-thioacetoxylpropyl)benzimidazol-2-yl)pyridine (3a).
A dichloromethane solution (50 mL) of 2a (1.26 g, 320 mmol) and
thioacetic acid (0.69 mL, 9.7 mmol) was irradiated with a high-pressure
mercury lamp (400 W) under argon for 2 h. The solution was washed
with saturated aqueous NaHCO3 solution, dried over Na2SO4, and
concentrated under reduced pressure. The product was purified by
column chromatography (silica gel, dichloromethane:ethyl acetate )
3:1) to give 3a (1.31 g, 75%) as a pale yellow oil. 1H NMR (300 MHz,
CDCl3): δ 1.97 (s, 4H), 2.03 (m, 4H), 2.70 (t, 4H), 4.76 (t, 4H), 7.37
(m, 4H), 7.48 (m, 2H), 7.91 (q, 2H), 8.03 (t, 1H), 8.38 (d, 2H). DI-MS
(EI): m/z 543, calcd exact mass 543.18.
2,6-Bis(1′-(6-thioacetoxyhexyl)benzimidazol-2-yl)pyridine (3b). A
dichloromethane solution (50 mL) of 2b (3.05 g, 6.40 mmol) and
thioacetic acid (1.37 mL, 19.2 mmol) was irradiated with a high-pressure
mercury lamp (400 W) under argon for 2 h. The solution was washed
with saturated aqueous NaHCO3 solution, dried over Na2SO4, and
concentrated under reduced pressure. The product was purified by
column chromatography (silica gel, dichloromethane:ethyl acetate )
3:1) to give 3b (4.02 g, equivalent yield) as a pale yellow oil. 1H NMR
(300 MHz, CDCl3): δ 1.10 (m, 8H), 1.27 (m, 4H), 1.86 (m, 4H), 2.20
(s, 6H), 2.61 (t, 4H), 4.69 (t, 4H), 7.33 (m, 4H), 7.45 (m, 2H), 7.86
(m, 2H), 8.06 (t, 1H), 8.32 (d, 2H). DI-MS (EI): m/z 627, calcd exact
mass 627.27.
1
give 3e (3.56 g, equivalent yield) as a pale yellow oil. H NMR (300
MHz, CDCl3): δ 1.00-1.25 (m, 32H), 1.54 (m, 4H), 1.71 (m, 4H),
2.32 (s, 6H), 2.85 (t, 4H), 4.71 (t, 4H), 7.33 (m, 4H), 7.45 (m, 2H),
7.87 (m, 2H), 8.06 (t, 1H), 8.32 (d, 2H). DI-MS (EI): m/z 795, calcd
exact mass 795.458.
2,6-Bis(1′-(3-mercaptopropyl)benzimidazol-2-yl)pyridine (4a). So-
dium borohydride (1.31 g, 2.4 mmol) was added to a DMAc solution
(50 mL) of 3a (1.31 g, 2.4 mmol). The mixture was stirred at room
temperature for 1 h. After addition of water to the solution, the product
was extracted with dichloromethane, dried over Na2SO4, and concen-
trated under reduced pressure. The product was then purified by column
chromatography (silica gel, dichloromethane:ethyl acetate ) 3:1) to
give 4a (0.5 g, 93%) as a colorless solid. 1H NMR (300 MHz, CDCl3):
δ 2.32 (m, 4H), 2.94 (q, 4H), 4.79 (t, 4H), 7.33 (m, 4H), 7.45 (m, 2H),
7.86 (q, 2H), 8.06 (t, 1H), 8.31 (d, 2H). DI-MS (EI): m/z 459, calcd
exact mass 459.16.
2,6-Bis(1′-(6-thiohexyl)benzimidazol-2-yl)pyridine (4b). Sodium
methoxide (2.04 g, 38 mmol) was added to a 2-propanol solution (500
mL) of 3b (1.00 g, 1.6 mmol), and the mixture was vigorously stirred
under ambient conditions at room temperature for 48 h. The solvent
was removed under reduced pressure. After addition of water to the
solution, the product was extracted with chloroform, dried over Na2-
SO4, and concentrated under reduced pressure. The product was then
purified by column chromatography (silica gel, dichloromethane:ethyl
1
acetate ) 3:1) to give 4b (0.77 g, 89%) as a colorless solid. H NMR
(300 MHz, CDCl3): δ 1.11 (m, 8H), 1.76 (m, 4H), 4.70 (t, 4H), 4.85
(t, 4H), 7.35 (m, 4H), 7.46 (m, 2H), 7.88 (m, 2H), 8.07 (t, 1H), 8.32
(d, 2H). DI-MS (EI): m/z 541, calcd exact mass 541.23.
2,6-Bis(1′-(8-thiooctyl)benzimidazol-2-yl)pyridine (4c). Sodium
methoxide (2.04 g, 38 mmol) was added to a 2-propanol solution (500
mL) of 3c (1.02 g, 1.5 mmol), and the mixture was vigorously stirred
under ambient conditions at room temperature for 48 h. The solvent
was removed under reduced pressure. After addition of water to the
solution, the product was extracted with chloroform, dried over Na2-
SO4, and concentrated under reduced pressure. The product was then
purified by column chromatography (activated alumina, chloroform)
2,6-Bis(1′-(8-thioacetoxyoctyl)benzimidazol-2-yl)pyridine (3c). A
dichloromethane solution (50 mL) of 2c (2.41 g, 4.53 mmol) and
thioacetic acid (3.2 mL, 45.3 mmol) was irradiated with a high-pressure
mercury lamp (400 W) under argon for 3 h. The solution was washed
with saturated aqueous NaHCO3 solution, dried over Na2SO4, and
concentrated under reduced pressure. The product was purified by
column chromatography (silica gel, hexane:dichloromethane:methanol
1
to give 4c (0.83 g, 93%) as a colorless solid. H NMR (300 MHz,
CDCl3): δ 1.28 (m, 16H), 1.65 (m, 4H), 1.84 (m, 4H), 2.66 (t, 4H),
4.73 (t, 4H), 7.36 (m, 4H), 7.48 (m, 2H), 7.87 (m, 2H), 8.05 (t, 1H),
8.34 (d, 2H). ESI-FT-ICR-MS: m/z 598.303 (M + H+), calcd exact
mass 598.304 (M + H).
1
) 5:5:1) to give 3c (3.09 g, equivalent yield) as a pale yellow oil. H
NMR (300 MHz, CDCl3): δ 1.02-1.25 (m, 16H), 1.33 (m, 4H), 1.75
(m, 4H), 2.30 (s, 6H), 2.71 (t, 4H), 4.69 (t, 4H), 7.36 (m, 4H), 7.47
(m, 2H), 7.87 (m, 2H), 8.07 (t, 1H), 8.31 (d, 2H). DI-MS (EI): m/z
683, calcd exact mass 683.333.
2,6-Bis(1′-(10-thioacetoxydecyl)benzimidazol-2-yl)pyridine (3d).
A dichloromethane solution (50 mL) of 2d (1.68 g, 2.86 mmol) and
thioacetic acid (2.0 mL, 28.6 mmol) was irradiated with a high-pressure
mercury lamp (400 W) under argon for 3 h. The solution was washed
with saturated aqueous NaHCO3 solution, dried over Na2SO4, and
concentrated under reduced pressure. The product was purified
by column chromatography (silica gel, hexane:ethyl acetate ) 1:1) to
give 3d (2.09 g, 99%) as a pale yellow oil. 1H NMR (300 MHz,
CDCl3): δ 1.00-1.25 (m, 24H), 1.50 (m, 4H), 1.73 (m, 4H), 2.31 (s,
2,6-Bis(1′-(10-thiodecyl)benzimidazol-2-yl)pyridine (4d). An aque-
ous solution (5 mL) of potassium carbonate (0.30 g, 2.2 mmol) was
added to an ethanol solution (300 mL) of 3d (0.35 g, 0.47 mmol). The
mixture was vigorously stirred under ambient conditions at room
temperature for 48 h. The solvent was removed under reduced pressure.
After addition of water to the solution, the product was extracted with
chloroform, dried over Na2SO4, and concentrated under reduced
pressure. The product was then purified by column chromatography
(activated alumina, chloroform) to give 4d (0.25 g, 80%) as a colorless
1
solid. H NMR (300 MHz, CDCl3): δ 1.23 (m, 20H), 1.37 (m, 4H),
1.68 (m, 4H), 1.83 (m, 4H), 2.69 (t, 4H), 4.71 (t, 4H), 7.38 (m, 4H),
7.47 (m, 2H), 7.88 (m, 2H), 8.05 (t, 1H), 8.34 (d, 2H). ESI-FT-ICR-
MS: m/z 654.366 (M + H+), calcd exact mass 654.366 (M + H).
9
J. AM. CHEM. SOC. VOL. 128, NO. 40, 2006 13093